| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.57 | 0.04 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |